Swissmedic constantly observes ongoing scientific, regulatory and technological developments in the therapeutic products sector that could impact therapeutic products regulation going forwards. The Agency’s structured horizon scanning process enables it to recognise relevant trends at an early stage, make informed decisions and address new regulatory challenges at an early stage.
In concrete terms, Swissmedic monitors relevant websites, such as those of partner authorities, specialist journals and market analysis providers. Regular internal Specialist Group meetings and meetings with international partner authorities are also held. The knowledge obtained is used among other things as a basis for decisions on proactively adapting the regulatory framework. Activities currently focus on developments in artificial intelligence, digitalisation and new therapeutic procedures. The horizon scanning process supports Swissmedic in fulfilling its roles as a forward-looking, innovation-friendly regulatory authority.
Contact